Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Optinose AS
AS
Active
Org 982483131
Gaustadalléen 21, 0349
Oslo
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 2000 · 25 years old
0 employees
www.optinose.no
Monitor
Share
Norway
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
Optinose AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
65M
49M
32M
16M
0M
2018: 50M
50M
2018
2019: 5M (-90% vs 2018)
5M
-90%
2019
2020: 1M (-80% vs 2019)
1M
-80%
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 52M (+5100% vs 2021)
52M
+5100%
2022
EBITDA
NOK millions
68M
45M
22M
0M
-23M
2018: 46M
46M
2018
2019: 0M (-100% vs 2018)
0M
-100%
2019
2020: -5M
-5M
2020
2021: -3M (+40% vs 2020)
-3M
+40%
2021
2022: 50M (+1767% vs 2021)
50M
+1767%
2022
Income statement
NOK thousands
Item
2022
2021
2020
2019
2018
Revenue
51 600
1 043
1 056
4 799
50 398
Staff expenses
−0
−0
−0
−0
−0
EBITDA
49 650
−3 180
−4 739
−290
46 046
Depreciation & amort.
−0
−0
−2
−1
−1
EBIT
49 650
−3 180
−4 741
−291
46 045
Net financials
−203
−349
−1 137
−6 585
−6 298
Profit before tax
49 447
−3 529
−5 878
−6 876
39 747
Tax
−0
−0
−0
−0
−0
Net profit
49 447
−3 529
−5 878
−6 876
39 747
Balance sheet
NOK thousands
Item
2022
2021
2020
2019
2018
Total assets
45 838
2 249
3 743
5 111
45 713
Equity
45 838
−3 632
−102
−17 683
−10 807
Long-term debt
0
0
0
0
48 794
Short-term debt
0
5 881
3 845
22 794
7 726
Total debt
0
5 881
3 845
22 794
56 520
Financial ratios
5-year trend
EBITDA margin
96,2 %
This company
15,8 %
Market median
This company
Market median
509% above market
2018
2022
Equity ratio
100,0 %
This company
38,2 %
Market median
This company
Market median
162% above market
2018
2022
Return on equity
107,9 %
This company
18,4 %
Market median
This company
Market median
486% above market
2018
2022
Net profit margin
95,8 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2018
2022
Asset turnover
1,13×
This company
1,12×
Market median
This company
Market median
1% above market
2018
2022
Debt / equity
0,00×
This company
0,62×
Market median
This company
Market median
100% below market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
More on Optinose AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
